InvestorsHub Logo
Followers 5
Posts 113
Boards Moderated 0
Alias Born 02/21/2017

Re: None

Thursday, 01/10/2019 10:35:18 AM

Thursday, January 10, 2019 10:35:18 AM

Post# of 704607
I'm certainly no expert in Bio buyouts, licensing deals, or mergers but from purely a business standpoint, how can any potential suitor be interested before, at a minimum, top line data is released? Am I missing something. If I'm a M&A guy at big pharma there has to be a way to value the purchase or licensing. How could this even begin to happen before data is available? I would be interested in other's input about this just conceptually.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News